Indianapolis, IN, United States of America

Keith L March

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Angiotech Pharmaceuticals & Advanced Research Tech. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith L March. Retrieved from https://idiyas.com/inventor/keith-l-march

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 83(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Keith L March

Introduction

Keith L March is a notable inventor based in Indianapolis, IN. He has made significant contributions to the field of medicine, particularly in the area of cardiovascular treatments. His innovative approach has led to the development of a unique patent that addresses critical health issues.

Latest Patents

Keith L March holds a patent for "Intrapericardial delivery of anti-microtubule agents." This patent involves methods and compositions for intra-pericardial administration of anti-microtubule agents, which are suitable for treating or preventing various diseases affecting the pericardium, heart, or coronary vasculature. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Keith is associated with Angiotech Pharmaceuticals and Advanced Research Technologies, where he applies his expertise to develop innovative medical solutions. His work focuses on improving patient outcomes through advanced therapeutic methods.

Collaborations

One of his notable collaborators is William L Hunter, with whom he has worked on various projects aimed at enhancing cardiovascular health.

Conclusion

Keith L March's contributions to medical innovation, particularly through his patent on anti-microtubule agents, highlight his dedication to improving healthcare. His work continues to inspire advancements in the treatment of cardiovascular diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…